Clinical Trial Update: PK/PD of Ertapenem In Patients With TB [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated the pharmacokinetics and pharmacodynamics of ertapenem in patients with tuberculosis and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• ERTAPENEM (ertapenem)

Snippet

Sponsor: University Medical Center Groningen | Conditions: PK of Ertapenem in TB Patients | Phase 2 | Status: COMPLETED